Therefore, we aimed to evaluate sGRP78 in pediatric patients with B-lineage acute lymphoblastic leukemia (B-ALL) at diagnosis and investigate its association with stem cell markers (CD34 and CD38), lineage markers (CD10 and CD19). Here, CD38 is linked to acute lymphoblastic leukemia.